Results 141 to 150 of about 2,229 (169)

Topical Cyclosporine a (2%) Eyedrops in the Therapy of Atopic Keratoconjunctivitis and Keratoconjunctivitis Vernalis

2002
The therapy for atopic and vernal keratoconjunctivitis (AKC and VKC) is often not satisfactory. Conventional therapeutic regimens consist of anti-allergic substances. Topically used immunosupressives such as Cyclosporine A (CsA) eyedrops are still part of clinical trials.
I, Tomida, J, Bräuning, T, Schlote, P E, Heide, M, Zierhut   +4 more
openaire   +2 more sources

What's new in atopic keratoconjunctivitis

Acta Ophthalmologica, 2013
AbstractSpecific clinical features of atopic keratoconjunctivitis are well known in adults and lead to a severe ocular surface impairment. However in children’s keratoconjunctivitis, even if common vernal keratoconjunctivitis form predominates, some pediatric presentation differs and must be individualised.
openaire   +1 more source

[Treatment of atopic keratoconjunctivitis in childhood].

Klinische Monatsblatter fur Augenheilkunde, 1988
In recent years atopic keratoconjunctivitis has been diagnosed increasingly frequently in children and adolescents. At Innsbruck University Eye Clinic all the children suffering from this condition have so far been satisfactorily treated with therapeutic contact lenses and locally applied antibiotics and steroids.
G F, Kieselbach, W, Gensluckner
openaire   +1 more source

Omalizumab for severe atopic keratoconjunctivitis.

BMJ case reports, 2013
A 35-year-old patient received omalizumab (300 mg twice a month) for 2 years for a severe atopic keratoconjunctivitis (AKC) in order to reduce the risk for steroid-induced keratitis. After 4 months, quality of life and ocular symptoms improved, and the use of oral steroids was strongly reduced. The treatment was well tolerated.
Camille, Taillé, Serge, Doan, Catherine, Neukirch, Michel, Aubier   +3 more
openaire   +1 more source

Atopic Keratoconjunctivitis

American Journal of Ophthalmology, 1953
openaire   +3 more sources

Atopic Keratoconjunctivitis

American Journal of Ophthalmology, 1957
openaire   +2 more sources

Association between atopic keratoconjunctivitis and the risk of keratoconus

Acta Ophthalmologica, 2021
Shih-Feng Weng, Ren-Long Jan, Jhi-Joung Wang   +2 more
exaly  

Atopic Keratoconjunctivitis: Diagnosis and Treatment

Current Ophthalmology Reports, 2022
Sana Qureshi, Nandini Venkateswaran
openaire   +1 more source

IL-1α antibody inhibits dose-dependent exacerbation of eosinophilic inflammation by crude house-dust-mite antigen in the conjunctiva of an atopic keratoconjunctivitis mouse model

Current Eye Research, 2021
Yukiko Shiraki, Jun Shoji, Noriko Inada   +2 more
exaly  

Tear levels of interferon-γ, interleukin (IL) -2, IL-4 and IL-5 in patients with vernal keratoconjunctivitis, atopic keratoconjunctivitis and allergic conjunctivitis

Clinical and Experimental Allergy, 2000
E Uchio, Z Ikezawa
exaly